IGM Biosciences Inc. (IGMS) Misses Q3 EPS by 21c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q3 EPS of ($1.01), $0.21 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $520 thousand versus the consensus estimate of $230.56 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Trilogy Metals signs $35.6M investment deal with U.S. Dept. of War
• AiRWA receives Nasdaq deficiency notice over late 10-K filing